Tag Archives: The Stem Cell Blog

The Rock’s Very Honest CRISPR Tweet Sends Science Community into Frenzy – Inverse

Continue reading

2018-04-12 NEWS

Inverse

The Rock’s Very Honest CRISPR Tweet Sends Science Community into Frenzy
Inverse
The hotly anticipated video game-turned-romcom, Rampage, starring Dwayne “The Rock” Johnson premieres Friday, but bright and early Thursday morning, he was already nerding out on Twitter about the science behind the film. In Rampage, weaponized gene
The Market and Potential for CRISPR/Cas9 Gene Editing 2017-2023PR Newswire (press release)
CRISPR/Cas9 Gene Editing Market 2018 and Future Potential 2023 …Business Wire (press release)
From yogurt bacteria to fighting cancer: Franklin Institute honors gene-editing pioneerPhilly.com
Interesting Engineering –Genetic Literacy Project –Endpoints News
all 10 news articles »
Continue reading

2018-04-12 NEWS

MIT Technology Review

The gene therapy that cures “bubble boy disease” isn’t worth it to Glaxo
MIT Technology Review
An analyst at Goldman Sachs asked a troubling question this week about gene therapy. “Is curing patients a sustainable business model?” In social media, reactions were quick and sharp. “Cold and immoral.” “Capitalism at its finest.” But the Goldman
Lonza makes gene therapy ambitions clear with Texas plantBioPharma Dive
Recon: GSK Sells Gene Therapy AssetsRegulatory Focus

all 4 news articles »

Continue reading

2018-04-12 NEWS

Bulletin of the Atomic Scientists

How do we control dangerous biological research?
Bulletin of the Atomic Scientists
At DARPA—the Defense Advanced Research Projects Agency, the US military’s research wing—the goal to “harness biology as technology” is one of four main areas of focus for its strategic investments. The biological sciences are expected to play a

Continue reading

2018-04-12 NEWS

A Call for ‘Smarter’ Immunotherapy Clinical Trials
Cancer Network
Immunotherapy has ushered in a new golden age of cancer treatment. Checkpoint inhibitors have offered new hope in the battling a variety of cancers. However, only about 20% of patients who receive these agents are benefitting. It is believed combining

and more »